A hyaluronan preparation (500-730 KDA) in the treatment of osteoarthritis: A review of clinical trials with Hyalgan®

International Journal of Clinical Practice

Volumn 56, Issue 10, 2002, Pages 804-813

  Maheu, E ^a   Ayral, X ^a   Dougados, M ^a  

^a Univeriste Rene Descartes ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRUM; CORTICOSTEROID; DEXAMETHASONE; HYALART; HYALURONIC ACID; LIDOCAINE; METHYLPREDNISOLONE ACETATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OSTENIL; PLACEBO; SUPLASYN; TRIAMCINOLONE HEXACETONIDE; UNCLASSIFIED DRUG; VISCORNEAL;

ARTICLE; BACTERIAL ARTHRITIS; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG POTENTIATION; DRUG SYNTHESIS; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HEMARTHROSIS; HIP OSTEOARTHRITIS; HUMAN; HUMEROSCAPULAR PERIARTHRITIS; INJECTION PAIN; KNEE ARTHROSCOPY; KNEE OSTEOARTHRITIS; KNEE PAIN; PHYSIOTHERAPY; POLYARTHRITIS; PRIORITY JOURNAL; PSEUDOGOUT; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SHOULDER PAIN; SYNOVITIS;

ADJUVANTS, IMMUNOLOGIC; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS, KNEE; RANDOMIZED CONTROLLED TRIALS;

EID: 0036956956     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Altman RD, Hochberg MC, Moskowitz RW, Schnitzer TJ, members of the ACR subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000; 43: 1905-1915.
2. Pendleton A, Arden N, Dougados M et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis 2000; 59: 936-944.
3. Lequesne M, Brandt K, Bellamy N et al. Guidelines for testing slow acting and disease modifying drugs in osteoarthritis. J Rheumatol 1994; 21(suppl 41): 65-71.
4. Group for the Respect of Ethics and Excellence in Science (GREES : osteoarthritis section): recommendations for the registration of drugs in the treatment of osteoarthritis. Ann Rheum Dis 1996; 55: 552-557.
5. Altman RD, Brandt K, Hochberg M et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results of a Workshop. Osteoarthritis Cartilage 1996; 4: 217-243.
6. Bellamy N, Kirwan J, Altman RD et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip and hand osteoarthritis: consensus development at OMERACT III. J Rheumatol 1997; 24: 799-802.
7. Desmarais MHL. Value of intra-articular injections in osteoarthritis. Ann Rheum Dis 1952; 11: 277-281.
8. Aviad AD, Houpt JB. The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it? J Rheumatol 1994; 21: 297-301.
9. Abatangelo G, O'Regan M. Hyaluronan: biological role and function in articular joints. Eur J Rheumatol Inflam 1995; 15: 9-16.
10. George E. Intra-articular hyaluronan treatment for osteoarthritis. Ann Rheum Dis 1998; 57: 637-640.
11. Brandt KD, Smith GN, Simon LS. Intraarticular injections of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum 2000; 43: 1192-1203.
12. Adams ME, Lussier AJ, Peyron JG. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee. Drug Saf 2000; 23: 115-130.
13. Balazs EA, Denlinger JL. Visco-supplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993; 20(suppl 39): 3-9.
14. Peyron JG. A new approach to the treatment of osteoarthritis: viscosupplementation. Osteoarthritis Cartilage 1993; 1: 85-87.
15. Rydell NW, Balasz EA. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin Orthop 1971; 80: 25-32.
16. Peyron JG, Balazs EA. Preliminary clinical assessment of Nahyaluronate injection into human arthritic joint. Pathol Biol (Paris) 1974; 22: 731-736.
17. Weiss C, Balazs EA, St. Onge R, Denlinger JL. Clinical studies of the intraarticular injection of Healon® (sodium hyaluronate) in the treatment of osteoarthritis of human knees. Semin Arthritis Rheum 1981; 11(suppl 1): 143-144.
18. Peyron JG. Intra-articular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol 1993; 20(suppl 39): 10-15.
19. Maheu E, Lamotte J, Lequesne M. Sel sodique de l'acide hyaluronique (hyaluronan) et gonarthrose. In: Kahn MF, Kuntz D, Dryll A et al, Eds. L'actualité rhumatologique. Paris: Expansion Scientifique Française, 1994; 324-339.
20. Bragantini A, Cassini M, De Bastiani G, Perbellini A. Controlled single-blind trial of intra-articularly injected hyaluronic acid (Hyalgan®) in osteoarthritis of the knee. Clin Trials J 1987; 24: 333-340.
21. Grecomoro G, Martonara C, Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 1987; 5: 137-141.
22. Dixon ASJ, Jacoby RK, Berry H, Hamilton EBD. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin 1988; 11: 205-213.
23. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (Hyalectin®) in osteoarthritis of the knee: A one year placebo-controlled trial. Osteoarthritis Cartilage 1993; 1: 97-103.
24. Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 1994; 53: 529-534.
25. Carrabba M, Paresce E, Angelini M, Perbellini A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflam 1995; 150): 25-31.
26. Lequesne MG, Mery C, Samson M, Gerard P. Index of severity for osteoarthritis of the hip and knee. Scan J Rheumatol 1987; 65(suppl): 85-89.
27. Formiguera Sala S, Esteve de Miguel R. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a short term study. Eur J Rheumatol Inflam 1995; 15(1): 33-38.
28. Altman RD, Moskowitz R. and the Hyalgan study group. Intra-articular sodium hyaluronate (Hyalgan®) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 1998; 25: 2203-2212.
29. Bellamy N, Ed. WOMAC osteoarthritis index: a users' guide. London, Ontario: Victoria Hospital; 1995.
30. Huskisson EC, Donelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 1999; 38: 602-607.
31. Maheu E, Guillou GB. Intra-articular steroid therapy for steoarthritis of the knee. Prescrire Int 1995; 4: 26-27.
32. Creamer P. Intra-articular corticosteroids injections in osteoarthritis: do they work and if so, how? Ann Rheum Dis 1997; 56: 634-636.
33. Leardini G, Franceschini M, Mattara L et al. Intra-articular sodium hyaluronate (Hyalgan®) in gonarthrosis. Clin Trials J 1987; 24: 341-350.
34. Leardini G, Mattara L, Franceschini M, Perbellini A. Intra-articular treatment of knee osteoarthritis: a comparative study between hyaluronic acid and 6-methyl prednisolone acetate. Clin Exp Rheumatol 1991; 9: 375-381.
35. Pietrogrande V, Melanotte PL, D'Agnolo B et al. Hyaluronic acid versus methylprednisolone intraarticularly injected for treatment of osteoarthritis of the knee. Curr Ther Res 1991; 50: 691-701.
36. Grecomoro G, Piccione F, Letizia G. Therapeutic synergism between hyaluronic acid and dexamethasone in the intra-articular treatment of osteoarthritis of the knee: a preliminary open study. Curr Med Res Opin 1992; 13: 49-55.
37. Jones A, Pattrick M, Doherty S, Doherty M. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage 1995; 3: 269-273.
38. Guidolin DD, Pasquali-Ronchetti I, Lini E et al. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-750 kDa sodium hyaluronate (Hyalgan®) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthritis Cartilage 2001; 9: 371-381.
39. Carrabba M, Paresce E, Angelini M et al. The intra-articular treatment of osteoarthritis of the knee: a comparative study between hyaluronic acid (Hyalgan®) and orgotein. Eur J Rheumatol Inflam 1992; 12: 47-57.
40. Graf J, Neusel E, Schneider E, Niethard FU. Intra-articular treatment with hyaluronic acid in osteoarthritis of the knee joint: a controlled clinical trial versus mucopolysaccharide polysulfic acid ester. Clin Exp Rheumatol 1993; 11: 367-372.
41. Kotz R, Kolarz G. Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles. Am J Orthop 1999; 27(suppl 11S): 5-7.
42. Leardini G, Perbellini A, Franceschini M, Mattara L. Intra-articular injections of hyaluronic acid in the treament of painful shoulder. Clin Ther 1988; 10: 521-526.
43. Rovetta G, Monteforte P. Intraarticular injection of sodium hyaluronate plus steroid versus steroid in adhesive capsulitis of the shoulder. Int J Tissue Reac 1998; 20: 125-130.
44. Bragantini A, Molinaroli F. A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Curr Ther Res 1994; 55: 319-330.
45. Listrat V, Ayral X, Patarnello F et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 1997; 5: 153-160.
46. Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 1998; 16: 441-449.
47. Pasquali-Ronchetti I, Guerra D, Taparelli F et al. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan®) and methylprednisolone acetate (Depomedrol®) in osteoarthritis. Rheumatology 2001; 40: 158-169.
48. Jubb RW, Piva S, Beinat L et al. Structure modifying study of hyaluronan (500-750 kDa, Hyalgan) on osteoarthritis of the knee. Arthritis Rheum 2001; 44(suppl): S155.
49. Lohmander LS, Dalen N, Englund G et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 1996; 55: 424-431.
50. Lussier A, Cividino AA, McFarlane CA et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from the clinical practice. J Rheumatol 1996; 23: 1579-1585.
51. Dougados M, Gueguen A, Nguyen M et al. Longitudinal radiologic evaluation of osteoarthritis of the knee. J Rheumatol 1992; 19: 378-384.
52. Felson DT, Lawrence RC, Hochberg MC et al. Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med 2000; 133: 726-737.
53. Scali JJ. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a long term study. Eur J Rheumatol Inflamm 1995; 15(1): 57-62.
54. Disla E, Infante R, Fahmy A et al. Recurrent acute calcium pyrophosphate dihydrate arthritis following intraarticular hyaluronate injection. Arthritis Rheum 1999; 42: 1302-1303.
55. Luzar MJ. Pseudogout following intraarticular injection of sodium hyaluronate. Arthritis Rheum 1998; 41: 939-941.
56. Maillefert JF, Hirschhorn P, Pascaud F et al. Acute attack of chondrocalcinosis after intraarticular injections of hyaluronan. Rev Rhum (English edn) 1997; 64: 593-594.
57. Puzi L, Pianon M, Piero SG, Todeco S. Pseudogout and intraarticular hyaluronate injections. Comment. Arthritis Rheum 2000; 43: 1660-1661.
58. Daumen-Legré V, Pham T, Acquaviva PC, Lafforgue P. Evaluation of safety and efficacy of viscosupplementation in knee osteoarthritis with chondrocalcinosis. Arthritis Rheum 1999; 42(suppl 9): S158.
59. Puttick MPE, Wade JP, Chalmers A et al. Acute local reactions after intraarticular Hylan for osteoarthritis of the knee. J Rheumatol 1995; 22: 1311-1314.
60. Pullman-Mooar S, Mooar P, Sieck M et al. Are there distinctive inflammatory flares of synovitis after Hylan GF intraarticular injections? Arthritis Rheum 1999; 42(9 suppl): S295.
61. Allen E, Krohn K. Adverse reaction to hylan GF-20. J Rheumatol 2000; 27: 1572.
62. Martens PB. Bilateral symmetric inflammatory reaction to hylan G-F 20 injection. Arthritis Rheum 2001; 44: 978-979.